BTSG BrightSpring (BTSG) Q4 FY25 earnings call
BrightSpring delivered robust Q4 and full-year FY25 results, driven by strong growth in Pharmacy Solutions and Provider Services, strategic M&A, and operational efficiencies. The company successfully divested its Community Living business and acquired significant home health assets, strengthening its balance sheet and exceeding leverage targets. Management is focused on continued volume growth, margin expansion through efficiency, and integrating new acquisitions, while navigating revenue headwinds from IRA and generic conversions in FY26.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
BTSG operating KPIs by quarter
| KPI | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| LDDs | 153We continue to see strong volume performance from both brand LDDs and generics, and we added 4 exclusive and UltraAR LDDs to our portfolio in the first quarter, bringing our total number of LDDs to 153.Source: earnings call transcript | 155During the quarter, we added 2 ultra-narrow network LDDs to our portfolio bringing the total number of LDDs to 155.Source: earnings call transcript | +1.3% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.